We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $67.5B
1-Year Est. Return 28.09%
This Fund
S&P 500
This Quarter Est. Return
+0.52%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$15.3B
AUM Growth
+$933M
Cap. Flow
+$1.09B
Cap. Flow %
7.1%
Top 10 Hldgs %
20.85%
Holding
1,816
New
17
Increased
573
Reduced
1,124
Closed
101

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$111M
2
AMZN icon
Amazon
AMZN
+$95.9M
3
MSFT icon
Microsoft
MSFT
+$91.8M
4
ROP icon
Roper Technologies
ROP
+$69.8M
5
PX
Praxair Inc
PX
+$68.1M

Top Sells

Rank Stock Value
1
BF.B icon
Brown-Forman Class B
BF.B
+$28.4M
2
BDX icon
Becton Dickinson
BDX
+$28M
3
GWW icon
W.W. Grainger
GWW
+$20.5M
4
LOW icon
Lowe's Companies
LOW
+$15M
5
TGT icon
Target
TGT
+$10.7M

Sector Composition

Rank Sector Weight
1 Technology 19.5%
2 Financials 13.66%
3 Healthcare 12.92%
4 Consumer Discretionary 10.42%
5 Industrials 10.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACCO icon
1576
Acco Brands
ACCO
$369M
$169K ﹤0.01%
13,450
-2,171
-14% -$27.2K
ESI icon
1577
Element Solutions
ESI
$9.12B
$168K ﹤0.01%
17,397
+803
+5% +$8.58K
WT icon
1578
WisdomTree
WT
$2.97B
$168K ﹤0.01%
18,333
-2,290
-11% -$24.7K
IRDM icon
1579
Iridium Communications
IRDM
$4.85B
$165K ﹤0.01%
14,685
-5,816
-28% -$69.6K
CTRE icon
1580
CareTrust REIT
CTRE
$10.2B
$161K ﹤0.01%
12,002
-1,504
-11% -$22.3K
NH
1581
DELISTED
NantHealth, Inc
NH
$159K ﹤0.01%
3,474
-574
-14% -$28.8K
IBRX icon
1582
ImmunityBio
IBRX
$7.44B
$158K ﹤0.01%
40,512
-6,677
-14% -$29.3K
MCRB icon
1583
Seres Therapeutics
MCRB
$48M
$157K ﹤0.01%
1,068
-176
-14% -$33.8K
JCP
1584
DELISTED
J.C. Penney Company, Inc.
JCP
$157K ﹤0.01%
51,892
-5,932
-10% -$21.4K
BEL
1585
DELISTED
Belmond Ltd.
BEL
$157K ﹤0.01%
14,044
-1,794
-11% -$22.1K
FORM icon
1586
FormFactor
FORM
$8.11B
$156K ﹤0.01%
11,452
+763
+7% +$11K
AUD
1587
DELISTED
Audacy, Inc.
AUD
$156K ﹤0.01%
16,214
-2,616
-14% -$27.2K
RPT
1588
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
$155K ﹤0.01%
12,512
-1,573
-11% -$19.9K
WFT
1589
DELISTED
Weatherford International plc
WFT
$155K ﹤0.01%
67,798
-7,024
-9% -$22.4K
PACB icon
1590
Pacific Biosciences
PACB
$422M
$154K ﹤0.01%
75,182
-2,831
-4% -$7.35K
LADR
1591
Ladder Capital
LADR
$1.25B
$152K ﹤0.01%
10,088
-1,627
-14% -$23.8K
LUMO
1592
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$151K ﹤0.01%
2,317
-381
-14% -$27K
TWNK
1593
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
$151K ﹤0.01%
10,233
-1,652
-14% -$23.1K
NE
1594
DELISTED
Noble Corporation
NE
$150K ﹤0.01%
40,321
-4,922
-11% -$21.9K
SCS
1595
DELISTED
Steelcase
SCS
$147K ﹤0.01%
10,781
-1,741
-14% -$25.5K
CMRX
1596
DELISTED
Chimerix, Inc.
CMRX
$145K ﹤0.01%
27,806
-4,500
-14% -$22.8K
FSP
1597
Franklin Street Properties
FSP
$44.8M
$140K ﹤0.01%
16,688
-2,093
-11% -$19.4K
PRDO icon
1598
Perdoceo Education
PRDO
$1.9B
$140K ﹤0.01%
10,683
-1,356
-11% -$17.4K
AVDL
1599
DELISTED
Avadel Pharmaceuticals
AVDL
$139K ﹤0.01%
19,053
-3,085
-14% -$27.1K
NEOS
1600
DELISTED
Neos Therapeutics, Inc
NEOS
$138K ﹤0.01%
16,571
-2,724
-14% -$26K

Similar funds

ProShare Advisors's Q1 2018 Portfolio in Review

As of Q1 2018, ProShare Advisors held 1,816 positions worth $15.3B, up 6.5% from $14.4B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

ProShare Advisors deployed $1.09B of net new capital in Q1 2018, opening 17 new positions and adding to 573 existing holdings. Its largest new stake was CoStar Group: 93,260 shares worth $3.38M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Brown-Forman Class B, an estimated $28.4M trimmed.

  • ProShare Advisors's largest Q1 2018 buy was CoStar Group: 93,260 shares worth $3.38M.
  • ProShare Advisors added most to Apple in Q1 2018, an estimated $111M increase.
  • ProShare Advisors's biggest Q1 2018 reduction was Brown-Forman Class B, cutting an estimated $28.4M.
  • ProShare Advisors fully exited Bioverativ Inc. Common Stock in Q1 2018, selling an estimated $3.8M.
  • ProShare Advisors's ten largest holdings make up 21% of its $15.3B portfolio in Q1 2018.
  • ProShare Advisors opened 17 new positions and closed 101 in Q1 2018.
  • ProShare Advisors's portfolio value rose 6.5% quarter-over-quarter to $15.3B.

Based on ProShare Advisors's 13F filing for Q1 2018, filed 14 May 2018.